3.47

4.41% -0.16

After Hours: 3.47

908 Devices Inc (MASS)

Overview News Price History Option Chain Financials Discussions Forecast

908 Devices Inc stock is traded at $3.47, with a volume of 90,181. It is down -4.41% in the last 24 hours and down -12.15% over the past month. 908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

Previous Close:

$3.63

Open:

$3.58

24h Volume:

90,181

Relative Volume:

0.45

Market Cap:

$119.91M

Revenue:

$50.23M

Net Income/Loss:

$-36.40M

P/E Ratio:

-2.916

EPS:

-1.19

Net Cash Flow:

$-27.10M

1W Performance:

-0.86%

1M Performance:

-12.15%

6M Performance:

-54.04%

1Y Performance:

-47.90%

1-Day Range:

$3.44

$3.63

1-Week Range:

$3.425

$3.85

52-Week Range:

$3.425

$12.51

908 Devices Inc Stock (MASS) Company Profile

Name

908 Devices Inc

Sector

Healthcare (1190)

Industry

Medical Devices (154)

Phone

978-729-4478

Address

645 SUMMER STREET, BOSTON

Employee

230

Twitter

Next Earnings Date

2024-08-06

Latest SEC Filings

MASS's Discussions on Twitter

908 Devices Inc Stock (MASS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-07-23	Initiated	Stephens	Overweight
Oct-15-21	Resumed	Cowen	Outperform
Jan-12-21	Initiated	Cowen	Outperform
Jan-12-21	Initiated	SVB Leerink	Outperform
Jan-12-21	Initiated	Stifel	Buy
Jan-12-21	Initiated	William Blair	Outperform

View All

908 Devices Inc Stock (MASS) Latest News

Sep 25, 2024

908 Devices stock hits 52-week low at $3.44 amid market challenges - Investing.com

Sep 25, 2024

Sep 23, 2024

4D Molecular Therapeutics (NASDAQ:FDMT) Shares Gap Down to $11.90 - Defense World

Sep 23, 2024

Bel Fuse Inc. (NASDAQ:BELFA) Shares Sold by Gabelli Funds LLC - Defense World

Sep 23, 2024

BEL partners with Reliasat to explore space sector opportunities - Defence Watch

Sep 23, 2024

Cantor Fitzgerald Lowers 4D Molecular Therapeutics (NASDAQ:FDMT) to Neutral - MarketBeat

Sep 23, 2024

B4 Investimenti acquires majority stake in Italian SME Gruppo Ferper - Real Deals

Sep 23, 2024

BEL Partners with Reliasat to Explore Space Sector Opportunities - Indiainfoline

Sep 23, 2024

Rhumbline Advisers Acquires 787 Shares of Bel Fuse Inc. (NASDAQ:BELFB) - Defense World

Sep 23, 2024

Sep 20, 2024

Insider Stock Buyers At 908 Devices Recouped Some Losses This Week - Simply Wall St

Sep 20, 2024

$268 million BARDA deal for Basilea - The Pharma Letter

Sep 20, 2024

Sep 19, 2024

Safety Services Management expands illicit drug-contaminated vehicle cleaning services to Illinois - isStories

Sep 19, 2024

4D Molecular Therapeutics (NASDAQ:FDMT) Shares Down 14.4% - MarketBeat

Sep 19, 2024

BEL and Reliasat Ink Agreement to Propel Space Product Collaboration - Devdiscourse

Sep 19, 2024

Basilea scores $268M BARDA funding deal to work on antifungals, antibiotics - Fierce Biotech

Sep 19, 2024

Sep 18, 2024

4D Molecular Therapeutics (NASDAQ:FDMT) Trading 4.2% Higher - Defense World

Sep 18, 2024

Sep 12, 2024

Blackline Safety Boosts Detection of Gas, Gamma Radiation with Launch of Next-Gen Safety Monitor - Firehouse

Sep 12, 2024

908 Devices stock hits 52-week low at $3.45 amid market challenges - Investing.com

Sep 12, 2024

Sep 11, 2024